Literature DB >> 4110519

Chemotherapy of vesical and prostatic tumours.

M Pavone-Macaluso.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4110519     DOI： 10.1111/j.1464-410x.1971.tb12090.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN： 0007-1331


× No keyword cloud information.
  8 in total

1.  Chemotherapy of bladder tumours.

Authors:  M Pavone-Macaluso
Journal:  Urol Res       Date:  1978

2.  Approaches to the treatment of bladder cancer at Stanford.

Authors:  F M Torti
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

3.  The prophylactic use of Thio-TEPA, an adjuvant in the treatment of bladder tumours.

Authors:  W Dobrzecki; A Kaczmarek
Journal:  Int Urol Nephrol       Date:  1977       Impact factor: 2.370

Review 4.  Chemotherapy of advanced transitional cell carcinoma of the uroepithelium.

Authors:  F M Torti; W G Harker
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

Review 5.  Chemotherapy in the management of invasive bladder cancer. A review.

Authors:  H Bush; N Thatcher; R Barnard
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

6.  Effects of single chemotherapeutic agents on development of urinary bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN) in rats.

Authors:  K Babaya; S Takahashi; H Momose; H Matsuki; K Sasaki; S Samma; S Ozono; Y Hirao; E Okajima
Journal:  Urol Res       Date:  1987

7.  Thiotepa versus Bacille Calmette-Guérin in Non-Muscle Invasive Bladder Cancer.

Authors:  Fatemeh Fallah; Mahdi Fallah; Raheleh Sadat Sajadi Nia
Journal:  Curr Urol       Date:  2012-12-21

8.  Cytotoxic chemotherapy in carcinoma of the bladder: a review.

Authors:  P H Smith
Journal:  J R Soc Med       Date:  1980-03       Impact factor: 18.000
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.